Windtree Therapeutics, Inc. (WINT)
0.012
0.00 (0.00%)
USD |
OTCM |
Mar 20, 16:00
Windtree Therapeutics Research and Development Expense (Quarterly) : 1.537M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agenus, Inc. | 7.511M |
| Curis, Inc. | 5.825M |
| Plus Therapeutics, Inc. | 2.941M |
| Enzon Pharmaceuticals, Inc. | -- |
| Halozyme Therapeutics, Inc. | 31.90M |